Pharmaceutical Executive-09-01-2018

Pharmaceutical Executive

Paul Perreault: The Global CEO

September 21, 2018

Features

38

9

Pharm Exec talks with CSL Limited’s top executive about the realities of running the global, Australian-headquartered specialty biotech company and sustaining a strong focus in a fast-encroaching era of disruptive technologies and new priorities in innovation and R&D.

Specialty Pharma’s Move to Mainstream

September 20, 2018

Features

38

9

While definitions for “specialty drug” vary-and distribution and pricing/reimbursement factors remain complicated-this once-niche treatment market may be poised to steer the future of prescription medicine and patient care.

Country Report: UK

September 01, 2018

Special Sponsored Section

38

9

Faced with looming uncertainties triggered by the upcoming Brexit, the United Kingdom’s life sciences sector, which constitutes one of the last big remaining bastions of British industry, is not about to rest on its laurels.

Pharmaceutical Executive, September 2018 Issue (PDF)

September 01, 2018

Issue PDF

38

9

Click the title above to open the Pharmaceutical Executive September 2018 issue in an interactive PDF format.